1,1-dichloroethene increases expression ISO RGD:733307 6480464 vinylidene chloride results in increased expression of LAPTM5 mRNA CTD PMID:26682919 1-naphthyl isothiocyanate increases expression ISO RGD:621838 6480464 1-Naphthylisothiocyanate results in increased expression of LAPTM5 mRNA CTD PMID:25380136 17alpha-ethynylestradiol affects expression ISO RGD:733307 6480464 Ethinyl Estradiol affects the expression of LAPTM5 mRNA CTD PMID:17555576 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of LAPTM5 mRNA CTD PMID:30165855 17beta-estradiol multiple interactions ISO RGD:621838 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LAPTM5 mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions ISO RGD:621838 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LAPTM5 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of LAPTM5 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:621838 6480464 Tetrachlorodibenzodioxin affects the expression of LAPTM5 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733307 6480464 Tetrachlorodibenzodioxin affects the expression of LAPTM5 mRNA CTD PMID:26377647 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:621838 6480464 Tetrachlorodibenzodioxin results in increased expression of LAPTM5 mRNA CTD PMID:21215274 , PMID:32109520 2,6-dinitrotoluene affects expression ISO RGD:621838 6480464 2, 6-dinitrotoluene affects the expression of LAPTM5 mRNA CTD PMID:21346803 2-butoxyethanol decreases expression ISO RGD:733307 6480464 n-butoxyethanol results in decreased expression of LAPTM5 mRNA CTD PMID:19812364 3,4-methylenedioxymethamphetamine increases expression ISO RGD:733307 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of LAPTM5 mRNA CTD PMID:26251327 3,4-methylenedioxymethamphetamine increases methylation ISO RGD:733307 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased methylation of LAPTM5 promoter CTD PMID:26251327 4,4'-diaminodiphenylmethane increases expression ISO RGD:621838 6480464 4, 4'-diaminodiphenylmethane results in increased expression of LAPTM5 mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane increases expression ISO RGD:733307 6480464 4, 4'-diaminodiphenylmethane results in increased expression of LAPTM5 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:733307 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of LAPTM5 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol affects methylation ISO RGD:733307 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of LAPTM5 gene CTD PMID:31683443 4,4'-sulfonyldiphenol decreases methylation ISO RGD:733307 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of LAPTM5 exon CTD PMID:33297965 4,4'-sulfonyldiphenol multiple interactions ISO RGD:733307 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with LIF protein] results in decreased expression of LAPTM5 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:733307 6480464 Fenretinide results in decreased expression of LAPTM5 mRNA CTD PMID:28973697 acetamide increases expression ISO RGD:621838 6480464 acetamide results in increased expression of LAPTM5 mRNA CTD PMID:31881176 aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of LAPTM5 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of LAPTM5 mRNA CTD PMID:21632981 , PMID:21641981 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of LAPTM5 mRNA CTD PMID:16249480 all-trans-retinoic acid multiple interactions EXP 6480464 [Tretinoin co-treated with arsenic trioxide] results in increased expression of LAPTM5 mRNA CTD PMID:15894607 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of LAPTM5 mRNA CTD PMID:15894607 more ... ammonium chloride affects expression ISO RGD:621838 6480464 Ammonium Chloride affects the expression of LAPTM5 mRNA CTD PMID:16483693 antirheumatic drug decreases expression EXP 6480464 Antirheumatic Agents results in decreased expression of LAPTM5 mRNA CTD PMID:24449571 aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of LAPTM5 mRNA CTD PMID:33212167 arsane affects methylation EXP 6480464 Arsenic affects the methylation of LAPTM5 gene CTD PMID:25304211 arsenic atom affects methylation EXP 6480464 Arsenic affects the methylation of LAPTM5 gene CTD PMID:25304211 arsenous acid multiple interactions EXP 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of LAPTM5 mRNA CTD PMID:15894607 arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of LAPTM5 mRNA CTD PMID:15894607 , PMID:20458559 atrazine increases expression ISO RGD:621838 6480464 Atrazine results in increased expression of LAPTM5 mRNA CTD PMID:36841081 benzo[a]pyrene affects expression EXP 6480464 Benzo(a)pyrene affects the expression of LAPTM5 mRNA CTD PMID:20106945 benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of LAPTM5 exon, Benzo(a)pyrene results in increased methylation of LAPTM5 promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of LAPTM5 3' UTR CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of LAPTM5 mRNA CTD PMID:21632981 , PMID:35870112 benzo[a]pyrene increases expression ISO RGD:733307 6480464 Benzo(a)pyrene results in increased expression of LAPTM5 mRNA CTD PMID:22228805 bisphenol A increases expression ISO RGD:621838 6480464 bisphenol A results in increased expression of LAPTM5 mRNA CTD PMID:18180321 bisphenol A increases expression ISO RGD:733307 6480464 bisphenol A results in increased expression of LAPTM5 mRNA CTD PMID:32156529 bisphenol A affects methylation ISO RGD:621838 6480464 bisphenol A affects the methylation of LAPTM5 promoter CTD PMID:27415467 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LAPTM5 mRNA CTD PMID:29718440 bisphenol A decreases expression ISO RGD:733307 6480464 bisphenol A results in decreased expression of LAPTM5 mRNA CTD PMID:25594700 , PMID:34585602 bisphenol A affects expression ISO RGD:621838 6480464 bisphenol A affects the expression of LAPTM5 mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:733307 6480464 bisphenol F results in increased expression of LAPTM5 mRNA CTD PMID:30951980 cadmium dichloride increases expression ISO RGD:733307 6480464 Cadmium Chloride results in increased expression of LAPTM5 mRNA CTD PMID:24982889 carbon nanotube decreases expression ISO RGD:733307 6480464 Nanotubes more ... CTD PMID:25554681 copper atom decreases expression ISO RGD:621838 6480464 Copper results in decreased expression of LAPTM5 mRNA CTD PMID:30556269 copper(0) decreases expression ISO RGD:621838 6480464 Copper results in decreased expression of LAPTM5 mRNA CTD PMID:30556269 Cuprizon increases expression ISO RGD:621838 6480464 Cuprizone results in increased expression of LAPTM5 mRNA CTD PMID:27523638 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of LAPTM5 mRNA CTD PMID:20106945 , PMID:27989131 dextran sulfate increases expression ISO RGD:733307 6480464 Dextran Sulfate results in increased expression of LAPTM5 mRNA CTD PMID:23894361 diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of LAPTM5 mRNA CTD PMID:15894607 , PMID:20458559 diarsenic trioxide multiple interactions EXP 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of LAPTM5 mRNA CTD PMID:15894607 dioxygen multiple interactions ISO RGD:621838 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LAPTM5 mRNA CTD PMID:33729688 diquat decreases expression ISO RGD:733307 6480464 Diquat results in decreased expression of LAPTM5 mRNA CTD PMID:36851058 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of LAPTM5 mRNA CTD PMID:29803840 emodin increases expression ISO RGD:733307 6480464 Emodin results in increased expression of LAPTM5 mRNA CTD PMID:15612046 ethanol increases expression ISO RGD:733307 6480464 Ethanol results in increased expression of LAPTM5 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression EXP 6480464 Ethyl Methanesulfonate results in increased expression of LAPTM5 mRNA CTD PMID:23649840 flavonoids increases expression ISO RGD:621838 6480464 Flavonoids results in increased expression of LAPTM5 mRNA CTD PMID:18035473 flutamide decreases expression ISO RGD:621838 6480464 Flutamide results in decreased expression of LAPTM5 mRNA CTD PMID:24136188 fonofos decreases methylation EXP 6480464 Fonofos results in decreased methylation of LAPTM5 promoter CTD PMID:22847954 formaldehyde decreases expression ISO RGD:621838 6480464 Formaldehyde results in decreased expression of LAPTM5 mRNA CTD PMID:17285311 formaldehyde decreases expression EXP 6480464 Formaldehyde results in decreased expression of LAPTM5 mRNA CTD PMID:28937961 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of LAPTM5 mRNA CTD PMID:23649840 furan decreases methylation ISO RGD:621838 6480464 furan results in decreased methylation of LAPTM5 gene, furan results in decreased methylation of LAPTM5 promoter CTD PMID:22079235 Genipin multiple interactions ISO RGD:733307 6480464 genipin inhibits the reaction [Lipopolysaccharides results in decreased expression of LAPTM5 mRNA] CTD PMID:22687549 gentamycin increases expression ISO RGD:621838 6480464 Gentamicins results in increased expression of LAPTM5 mRNA CTD PMID:22061828 hydrogen peroxide decreases secretion ISO RGD:733307 6480464 Hydrogen Peroxide results in decreased secretion of LAPTM5 mRNA CTD PMID:21179422 isotretinoin increases expression EXP 6480464 Isotretinoin results in increased expression of LAPTM5 mRNA CTD PMID:20436886 ketamine increases expression ISO RGD:621838 6480464 Ketamine results in increased expression of LAPTM5 mRNA CTD PMID:20080153 lidocaine increases expression ISO RGD:621838 6480464 Lidocaine results in increased expression of LAPTM5 mRNA CTD PMID:35283115 lipopolysaccharide multiple interactions ISO RGD:733307 6480464 genipin inhibits the reaction [Lipopolysaccharides results in decreased expression of LAPTM5 mRNA] CTD PMID:22687549 lipopolysaccharide increases expression ISO RGD:733307 6480464 Lipopolysaccharides results in increased expression of LAPTM5 mRNA CTD PMID:27339419 lipopolysaccharide decreases expression ISO RGD:733307 6480464 Lipopolysaccharides results in decreased expression of LAPTM5 mRNA CTD PMID:22687549 N-nitrosodimethylamine increases expression ISO RGD:621838 6480464 Dimethylnitrosamine results in increased expression of LAPTM5 mRNA CTD PMID:25380136 nickel atom increases expression EXP 6480464 Nickel results in increased expression of LAPTM5 mRNA CTD PMID:24768652 , PMID:25583101 ozone multiple interactions ISO RGD:733307 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of LAPTM5 mRNA CTD PMID:34911549 paracetamol affects expression ISO RGD:733307 6480464 Acetaminophen affects the expression of LAPTM5 mRNA CTD PMID:17562736 parathion decreases methylation EXP 6480464 Parathion results in decreased methylation of LAPTM5 promoter CTD PMID:22847954 phenobarbital increases expression ISO RGD:733307 6480464 Phenobarbital results in increased expression of LAPTM5 mRNA CTD PMID:23091169 pirinixic acid decreases expression ISO RGD:733307 6480464 pirinixic acid results in decreased expression of LAPTM5 mRNA CTD PMID:17426115 quercetin increases expression EXP 6480464 Quercetin results in increased expression of LAPTM5 mRNA CTD PMID:21632981 quinolin-8-ol increases expression ISO RGD:733307 6480464 Oxyquinoline results in increased expression of LAPTM5 mRNA CTD PMID:15612046 resveratrol multiple interactions ISO RGD:621838 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of LAPTM5 mRNA CTD PMID:25905778 resveratrol increases expression ISO RGD:621838 6480464 resveratrol results in increased expression of LAPTM5 mRNA CTD PMID:25905778 rotenone increases expression ISO RGD:733307 6480464 Rotenone results in increased expression of LAPTM5 mRNA CTD PMID:23186747 silicon dioxide increases expression ISO RGD:621838 6480464 Silicon Dioxide results in increased expression of LAPTM5 mRNA CTD PMID:32721576 sodium arsenite affects expression EXP 6480464 sodium arsenite affects the expression of LAPTM5 mRNA CTD PMID:20816728 Soman increases expression ISO RGD:621838 6480464 Soman results in increased expression of LAPTM5 mRNA CTD PMID:19281266 sotorasib multiple interactions EXP 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LAPTM5 mRNA CTD PMID:36139627 streptozocin multiple interactions ISO RGD:621838 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of LAPTM5 mRNA CTD PMID:25905778 terbufos decreases methylation EXP 6480464 terbufos results in decreased methylation of LAPTM5 promoter CTD PMID:22847954 tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of LAPTM5 mRNA CTD PMID:15336504 testosterone multiple interactions ISO RGD:621838 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LAPTM5 mRNA CTD PMID:32741896 testosterone enanthate affects expression EXP 6480464 testosterone enanthate affects the expression of LAPTM5 mRNA CTD PMID:17440010 tetrachloromethane increases expression ISO RGD:733307 6480464 Carbon Tetrachloride results in increased expression of LAPTM5 mRNA CTD PMID:27339419 , PMID:31919559 thioacetamide increases expression ISO RGD:621838 6480464 Thioacetamide results in increased expression of LAPTM5 mRNA CTD PMID:34492290 trametinib multiple interactions EXP 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LAPTM5 mRNA CTD PMID:36139627 triphenyl phosphate decreases expression ISO RGD:621838 6480464 triphenyl phosphate results in decreased expression of LAPTM5 mRNA CTD PMID:30589522 triptonide increases expression ISO RGD:733307 6480464 triptonide results in increased expression of LAPTM5 mRNA CTD PMID:33045310 triticonazole increases expression ISO RGD:621838 6480464 triticonazole results in increased expression of LAPTM5 mRNA CTD PMID:36084822 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of LAPTM5 mRNA CTD PMID:29154799 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of LAPTM5 mRNA CTD PMID:25979313 valproic acid increases methylation EXP 6480464 Valproic Acid results in increased methylation of LAPTM5 gene CTD PMID:29154799 vancomycin decreases expression ISO RGD:733307 6480464 Vancomycin results in decreased expression of LAPTM5 mRNA CTD PMID:18930951 vinclozolin affects expression ISO RGD:621838 6480464 vinclozolin affects the expression of LAPTM5 mRNA CTD PMID:19015723 vinclozolin increases expression ISO RGD:621838 6480464 vinclozolin results in increased expression of LAPTM5 mRNA CTD PMID:23034163